Merck Expects Moderating Keytruda Growth as Some Indications Approach Peak Revenue
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
11:48:15 AM UTC
SquawkNews
MERCK & CO INC: EXPECT KEYTRUDA & WINREVAIR BENEFIT TO FULLY UNWIND IN 4Q26; MAJORITY OF VACCINES BE